Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Neuland Laboratories Ltd. Share Price
Day's Range
Day's Range
Low
₹16,244.00
High
₹16,866.00
Price Summary
| Previous Close | ₹16,790.00 |
|---|---|
| Day's Range | ₹16,244.00 - ₹16,866.00 |
| Open | ₹16,460.00 |
| 52 Week Range | ₹11,011.00 - ₹19,747.00 |
| Volume | 49,667 |
| Market Cap | ₹0.02 |
| Previous Close | ₹16,581.85 |
|---|---|
| Day's Range | ₹16,250.00 - ₹16,855.00 |
| Open | ₹16,398.95 |
| 52 Week Range | ₹11,022.40 - ₹19,748.40 |
| Volume | 6,811 |
| Market Cap | ₹0.02 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 8,339.09 |
|---|---|
| Market Cap (₹ in Mn) | 0.02 |
| Dividend Yield(%) | 0.21 |
| Price/Earning (TTM) | 57.55 |
| TTM EPS (₹) | 283.71 |
| P/E Ratio | 59.57 |
| Book Value(₹) | 11.18 |
| PAT Margin (%) | 17.61 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 23.45 |
| Trade Value ( ₹ in Lacs) | 1,129.39 |
|---|---|
| Market Cap (₹ in Mn) | 0.02 |
| Dividend Yield(%) | 0.21 |
| Price/Earning (TTM) | 57.55 |
| TTM EPS (₹) | 283.71 |
| P/E Ratio | 59.57 |
| Book Value(₹) | 11.18 |
| PAT Margin (%) | 17.61 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 23.45 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 3283.6 | 14768.37 |
| Expenses | N/A | N/A |
| PBT | 389.82 | 3453.74 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 277.34 | 2594.25 |
About Neuland Laboratories Ltd.
| Founded | 1984 |
|---|---|
| Managing Director | Davuluri Saharsh Rao |
| NSE Symbol | NEULANDLAB |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,57,121.30 | 1,882.15 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,81,396.01 | 6,919.65 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,48,729.85 | 4,457.15 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,15,331.11 | 8,038.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,240.83 | 1,410.00 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,126.23 | 1,333.95 | 1,148.40 - 1,148.40 |
| Mankind Pharma Ltd. | 1,03,056.40 | 2,477.50 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,03,022.72 | 1,063.55 | 903.00 - 903.00 |
| Lupin Ltd. | 1,03,010.73 | 2,286.50 | 1,836.80 - 1,836.80 |
| Zydus Lifesciences Ltd. | 99,737.91 | 1,018.95 | 835.50 - 835.50 |
No Records Found
Latest News
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories submits earnings call intimation
Neuland Laboratories informs about press release
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about newspaper advertisement
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, Neuland Laboratories has informed that it enclosed copies of newspaper advertisement informing about the opening of a Special Window for transfer and dematerialization of physical shares, in accordance with SEBI Circular No. HO/38/13/11(2)2026- MIRSD-PoD/I/3750/2026 dated January 30,2026, as published in Financial Express and Nava Telangana on March 11, 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Neuland Laboratories Ltd. is ₹16,790.00 as of 2026-05-19.
The market capitalisation of Neuland Laboratories Ltd. is ₹20,949.73 as of 2026-05-18.
The 1-year return of Neuland Laboratories Ltd. is 463.00% as of 2026-05-19.
The P/E ratio of Neuland Laboratories Ltd. is 59.57 as of 2026-05-19.
The 52-week high and low of Neuland Laboratories Ltd. are ₹19,747.00 and ₹11,011.00, respectively, as of 2026-05-19.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
